A preliminary characterization of the Pneumocystis carinii dihydroorotate dehydrogenase.
Ittarat
I
I
Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor 48109.
Asawamahasakda
W
W
Meshnick
S R
SR
D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology; D000968:Antimycin A / Q000494:pharmacology; D053626:Atovaquone; D002478:Cells, Cultured; D000090722:Dihydroorotate Dehydrogenase; D006801:Humans; D009285:Naphthoquinones / Q000494:pharmacology; D010088:Oxidoreductases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D044925:Oxidoreductases Acting on CH-CH Group Donors; D011010:Pneumocystis / Q000201:enzymology* / Q000302:isolation & purification; D011020:Pneumonia, Pneumocystis / Q000382:microbiology; D011190:Potassium Cyanide / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012457:Salicylamides / Q000494:pharmacology
D000935:Antifungal Agents; D000090722:Dihydroorotate Dehydrogenase; D009285:Naphthoquinones; D012457:Salicylamides; D000968:Antimycin A; C005703:salicylhydroxamic acid; D010088:Oxidoreductases; D044925:Oxidoreductases Acting on CH-CH Group Donors; D011190:Potassium Cyanide; D053626:Atovaquone